chrisvoncsefalvay/vaers-outcomes huggingface dataset:
it's a slight discomfort; 3rd bi-cep , hard knot sitting on top of the bicep towards the shoulder. He gave it extremely high in the shoulder, I wonder if it was administered wrong?; 3rd bi-cep , hard knot sitting on top of the bicep towards the shoulder. He gave it extremely high in the shoulder, I wonder if it was administered wrong?; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 56 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Apr2021 (Lot number: EW0162) at the age of 56 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose of vaccination, lot number: EP6955, expiry: unknown, Anatomical Location: left arm), administration date: 19Mar2021, for Covid-19 immunization. The following information was reported: DISCOMFORT (non-serious) with onset Apr2021, outcome "unknown", described as "it's a slight discomfort"; PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset Apr2021, outcome "unknown", VACCINATION SITE MASS (non-serious) with onset Apr2021, outcome "not recovered" and all described as "3rd bi-cep , hard knot sitting on top of the bicep towards the shoulder. He gave it extremely high in the shoulder, I wonder if it was administered wrong?".  Additional information: The patient reported that he received Pfizer covid 19 vaccine, got second shot 09Apr2021, noticed next morning, 3rd bi-cep, hard knot sitting on top of the bicep towards the shoulder. The patient was not sure if something he should be worried about or just needed some time, this was day 7 still hadn't gone away, it was a slight discomfort, everything he read said it should go away about 2 to 4 days. It doesn't hurt. He has iced it. He gave it some time. They said to check it out for a day or two. The patient reported that he gave it extremely high in the shoulder, and the patient wondered if it was administered wrong. It was way up in the shoulder. It was almost at top of the shoulder where he injected the vaccine. He referred to HCP for symptoms that were bothersome and did not go away. There were no other products, patient history and investigation assessment. The patient had a primary doctor, but hasn't talked to him about this. He noticed the hard knot the next morning. He is not sure if appeared the night of the vaccine or that next morning. It is ongoing. It's not quite as hard as it was, but it is not going away. Time the vaccination was given was about 1245 or 1300. The patient got the first vaccine in left arm and it was given lower than it was this time and he had no reaction. No additional vaccines were administered on same date of the Pfizer suspect. No AE(s) required a visit to Emergency Room or Physician Office. There were no AE(s) following prior vaccinations. He doesn't get vaccines often. This is the first vaccine he has had in decades.   No follow-up attempts are possible. No further information is expected.
Headache, severe joint and muscle pain worst pain in my life, chills, nausea, and slight fever of 99
Case completed Covid vaccine series in February 2021, then was admitted to hospital for treatment of Covid in November 2021.
Information has been received from a pharmacist concerning a 72 year old female who on 12/5/01 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (invalid lot 8030L reported) (site unknown). Concomitant therapy on 12/5/01 included a dose of influenza virus vaccine (site unknown). The pt developed a local reaction that same day, the pharmacist referred to the reaction as an injection site reaction. It was noted that she was afebrile. No past vaccination information was available. No treatment was needed, but the pt sought unspecified medical attention. Additional information has been requested.
On 01/17/2021,  red splotches that looked like bug bites started showing up on my right leg, the next day they appeared on my left leg. They were located on my upper thighs down to my ankles on both legs. They had no pain and did not itch.  I had a combined total of approximately 25-30 of them . As of today's date they are  still healing and are approximately 95% gone.
This case was considered medically important (OMIC). Information regarding Prevnar was received from a physician regarding a 5 month old female who developed a fever and cellulitis around the injection site. At 5 months of age, the pt received the second dose on 1/23/04. The infant was reported as healthy. Indication for Prevnar was immunization. Product was administered on 1/23/04. Dose regimen was 0.5ml (IM). Concomitant medications were not reported. The infant received a dose of diphtheria, tetanus and acellular pertussis vaccine on 12/19/03. On 1/23/04, the infant developed a fever. The next day, redness was noted around the injection site. On 1/26/04, the infant was seen by the physician, who noted that the skin around the injection site was reddened, tender, and warm to the touch. The physician prescribed Augmentin and warm compresses for the cellulitis at the injection site.  The physician reported that the infant recovered.
Father said at midnight was itching and woke up with rash/hives on legs and arms. Taken to urgent care clinic and given BENADRYL. He did not have difficulty breathing or swallowing. He received vaccines at 1015am. He also had a smoothie with berries that day.
Foggy vision after 3rd dose/Vision has change after 3rd dose; Feeling crappy after 3rd dose; Body aches after 3rd dose; Chills after 3rd dose; Fever 102F after 3rd dose,Fever keeps coming back; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Foggy vision after 3rd dose/Vision has change after 3rd dose), FEELING ABNORMAL (Feeling crappy after 3rd dose), MYALGIA (Body aches after 3rd dose), CHILLS (Chills after 3rd dose) and PYREXIA (Fever 102F after 3rd dose,Fever keeps coming back) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Oct-2021, the patient experienced FEELING ABNORMAL (Feeling crappy after 3rd dose), MYALGIA (Body aches after 3rd dose), CHILLS (Chills after 3rd dose) and PYREXIA (Fever 102F after 3rd dose,Fever keeps coming back). On 04-Oct-2021, the patient experienced VISION BLURRED (Foggy vision after 3rd dose/Vision has change after 3rd dose). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, VISION BLURRED (Foggy vision after 3rd dose/Vision has change after 3rd dose) had not resolved and FEELING ABNORMAL (Feeling crappy after 3rd dose), MYALGIA (Body aches after 3rd dose), CHILLS (Chills after 3rd dose) and PYREXIA (Fever 102F after 3rd dose,Fever keeps coming back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Oct-2021, Body temperature: 102 (High) Fever 102F.         No concomitant medications were provided.   This case was linked to MOD-2021-339821 (Patient Link).
After the 2nd Phizer COVID 19 shot, my skin has broken out all over, my body. Very scratchy and the open  sores have not gone away.  I had no  problem before the Phiser COVID 19 shots. Is this normal?
pt to ED with c/o SOB, chest pain, cough, palpitations; positive for COVID; dx with ARF and COVID pneumonia; started on dexamethasone and antibiotics; outside the window for remdesivir; metabolic encephalopathy never improved; transitioned to comfort care; pt passed away in the hospital
Bad headache and very fatigued for 36 hours.   Most sever cold sore (HSV-1) I've ever had came on 6 days after. Haven't had one for 6 years.
pt recvd vax; day following inject of flu, lt upper arm became extremely sore, swollen & red; swelling extended down to wrist;
Left arm is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Left arm is sore".  Additional information: Patient had her shot at 11:20. Wanted to know if she could take Ibuprofen. Is Pfizer Covid shot. Has not taken Ibuprofen yet. Stated that her left arm is sore. Was told not to take it the day before the shot. Wanted to know what can she take for this.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Moderna COVID-19 vaccine was administered to patients past the published expiry date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine was administered to patients past the published expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was given by reporter. No treatment medication was given by reporter.  It was reported that the vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions
Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not receive the second vaccine dose yet and it is been more than 35 days since the first vaccine dose) had resolved.            No Relevant concomitant medications was reported.  Treatment information was not provided.
Sore arm, brain fog, 3 months of disrupted menstrual cycles and spotting, swollen breasts, swollen feet.
Patient admitted as observation on 7/24 due to acute respiratory failure with hypoxia. Patient was tested for COVID-19 and was positive on 7/22.
low grade fever; severe muscle aches; headache; fatigue; This case was reported by a consumer and described the occurrence of low grade fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th October 2020, the patient received the 1st dose of Shingrix. In October 2020, less than a week after receiving Shingrix, the patient experienced low grade fever, muscle pain, headache and fatigue. On an unknown date, the outcome of the low grade fever, muscle pain, headache and fatigue were not recovered/not resolved.   It was unknown if the reporter considered the low grade fever, muscle pain, headache and fatigue to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. After receiving Shingrix, the patient was experiencing severe muscle aches, low grade fever, headache and fatigue.
I've had a red rash (1/2 inch) pop up on my left forearm and both legs. It looks like a patch of dry skin, but it does not itch or burn.
Fever and extreme fatigue day after shot. More important, and the reason to report, today I've been very short of breath with any exertion, and heart feels like it's pounding.
Case number PHHY2016US179748 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 650821) on 21 Dec 2016. This report refers to a female patient of an unknown age. Medical history and concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: not reported) on an unknown date. On an unknown date, the patient experienced allergy to FLUVIRIN. The outcome, seriousness, causality of the event was not reported.
Rash on left arm for days after the injection. It was itchy and red and increased in size but weakened in color over the last few days. Then she noticed that her skin around her neck had small bumps. It seems maybe the problem has spread.
This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 76-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb and injection site erythema. On an unknown date, the outcome of the extensive swelling of vaccinated limb and injection site erythema were unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 75 or 76 years. The batch number and expiry date were not reported. After receiving SHINGRIX, the patient experienced redness and swelling at the injection site which swelled to double the normal size. This dose was not administered at the reporter's facility, so no further information was available.
Breakthrough case admission after two Janssen vaccines Janssen 3/25/21 Lot# 1802082;  Janssen 1/31/2022 Lot# 1855191
It was all a gastrointestinal issue. Vomiting, cramping, diarrhea, It was severe for about 4 days and stayed. It was very back and forth with symptoms. I took my own test at home, I took COVID test as well and they were all negative. I let it continue until I was able to see someone. I had a colonoscopy in December.
Patient had adverse reaction to HPV. Vitals was taken. BP 112/78 pulse 86 RR 16 Temp 97.6 denies pain. Patient was stabilized and monitored for 30 minutes. She was discharged stable
Pt came back on Friday 23 with swelling redness in his Lt deltoid was given shot on 21st he has also had fever and upset stomach.
Received Pfizer vaccine (first dose).  Almost 2 weeks later, I have a huge black and green bruise at injection site.
BURNING SENSATION IN FACE AND NECK; HEAD PRESSURE; LOW FEVER; HEADACHE; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A,  expiry: 14-DEC-2021) dose was not reported, administered on 07-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-OCT-2021, the patient experienced burning sensation in face and neck. On 07-OCT-2021, the patient experienced head pressure. On 07-OCT-2021, the patient experienced low fever. On 07-OCT-2021, the patient experienced headache. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from low fever, and had not recovered from burning sensation in face and neck, head pressure, and headache. This report was non-serious.
7/09/2006 9 A.M- LOCAL REACTION TO VACCINE OBSERVED AS SWELLING AROUND INJECTION SITE - ABOUT 1.5 INCHES IN DIAMETER NO OTHER SYMPTONS PRESENT AFTER.. 7/11/2006 -4.10 P.M  PATIENT IN QUESTION FAINTS IN CLASS OF DAYCARE(NOT PLAYING, NO STRENOUS ACTIVITY DONE PRIOR TO EVENT), PROFUSE SWEATING OBSERVED WITH SEIZURE-LIKE SYMPTONS INCL BODY CONVULSIONS, FOAMING AT MOUTH FOR ABOUT 1-2 MINS.PARAMEDICS ARRIVED AT 4.25 P.M AND CHECK VITALS AND RUSH PATIENT TO ER- VITALS ALL O.K CT SCAN, BLOOD TESTS ALL NORMAL.IV GIVEN AND PATIENT RELEASED AFTER OBSERVATION. 7/19/2006 - EEG DONE TO SEE IF ANY OTHER FACTORS STILL PRESENT..REPORT WAS NORMAL NO FURTHER INCIDENTS OBSERVED AS OF 07/20/2006
2nd dose received more than 5 months after the second; different COVID-19 vaccine for 1st and 2nd dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Oct-2021 and was forwarded to Moderna on 05-Oct-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (different COVID-19 vaccine for 1st and 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 5 months after the second) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: COVID-19 VACCINE NRVV AD on 25-Mar-2021.    On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (different COVID-19 vaccine for 1st and 2nd dose). On 03-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 5 months after the second). On 03-Sep-2021, INTERCHANGE OF VACCINE PRODUCTS (different COVID-19 vaccine for 1st and 2nd dose) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received more than 5 months after the second) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant treatment was provided. No treatment medication was provided. First dose lot number includes 1805031 and expiration date includes 31-DEC-2069 Patient had stated that No adverse events are experienced.
Nausea, Bloating,  slight head ache , blurred vision, weakness, no energy.
The patient received the COVID 19 vaccine.  As he waited after receiving the vaccine, the patient stated that he did not feel well and was having shortness of breath.  911 was called and the patient was assessed. The patient stated that his throat was not swelling and refused to remove his mask.  He did not appear to be wheezing and remained alert and oriented.  His breathing appeared  as someone who was hyperventilating. He continued to talk until the EMS arrived.  I got a blood pressure cuff and proceeded to check his blood pressure.  EMS arrived shortly and the patient stated he was feeling better.  He was after to stand and get on the stretcher and was transported to the hospital.        The patient was contacted the next day and stated his blood pressure on the ambulance was 140/90.  He said when he got to the hospital the wait was long.  He stated he was feeling better so he left and was not seen by the doctor.  He stated he was feeling fine and had no more shortness of breath.  He also stated he would not be getting the second dose of the vaccine.
States arrived at hotel approximately 6pm, having chills with headache that continued to worsen without temperature going up but not checked. Ambulance was called and he was taken to Hosp evaluated and admitted.
The patient is a 21 year old male with no significant past medical history who presented with chest pain.    The patient had developed flu-like symptoms the day after receiving the 2nd dose of the COVID vaccine on 4/21/21  several days prior to admission. His symptoms lasted a couple days then resolved on Thursday 4/22/2021, at which time he felt back to his normal state of health. On the morning of presentation on 4/24/2021, he woke up at 5 AM without any concerns, then about 15-20 minutes after waking up he developed sudden onset chest pain, described as chest tightness. The chest pain was worse when lying in certain positions or with taking deep breaths. He has never had similar symptoms in the past. He denies shortness of breath, lightheadedness, or syncope.    In the ED, labs showed elevated high sensitivity troponin 104 -> 136 -> 203, and EKG showed diffuse ST elevations. At the time of assessment in the ED, the patient is lying comfortably in the gurney and denies active chest pain.
About 2 weeks after the booster shot, intense itchiness randomly pops up on body (including feet, hands and scalp), with hives.  The more scratching, the more itchy and more hives. The itchiness and hives would go away in an hour or so, but would occur at other random parts of the body again. Shortly after. Tried Benadryl, didn?t work. Took 1 Zyrtec on 2/14 morning, no itchiness until 2/16 evening. Took second Zyrtec on 2/16 evening, the itchiness went away again. No dietary change, no personal care or home care products change, no new clothes, etc, since the booster shot.
2nd Twinrix given 4-14-04. After which she noted warm, raised pink hives size of quarter that evening & remembered she had seen sized hives after 1st shot 4-15-04 spoke to doctor who advised Benadryl PO & ice. 4-17 returned to office as instructed & seen by doctor, confined to left upper arm area 2 inch x 5 inch given 20 mg Prednisone three times- took daily complete by 4-19-04.
Six hours after injection of vaccine, I experienced nausea, moderate chills, headache, and a low fever which lasted for 6 hours. I also had numb fingertips which lasted for around 20 minutes right after the chills really set in. I'm not positive its related but two nights after my vaccine injection, I woke up at night because my feet were itching and hot. They also had the pins and needles sensation and these symptoms lasted around 20 to 30 minutes. I have never had that happen before so I assume it was vaccine related.